Skip to main content
. Author manuscript; available in PMC: 2009 Feb 15.
Published in final edited form as: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Nov 1;32(2):568–575. doi: 10.1016/j.pnpbp.2007.10.020

Figure 2.

Figure 2

Anxiety scores of substance abusers during a 3-month administration of n-3 PUFAs or placebo. Values are means±SEM. A comparison of the scores of the two patient groups by a repeated measures ANCOVA, with baseline values as covariates, revealed a significant difference (p=.023). The effect size was large (f=.567).